Drug
Niaspan
Niaspan: highest development phase Not Applicable, developed by Merck KGaA. 1 trial record tracked on RxWires.
- Highest phase
- Not Applicable
- Developer
- Merck KGaA
Trials
| Drug | Phase | Indication |
|---|---|---|
| Niaspan NCT00232531 | Not Applicable | Atherosclerosis |
Latest
No recent events.
Follow Niaspan on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.